$SRF Financial performance and key operating metrics (consolidated) Operating Revenue for Q1FY27 is Rs. 5,033 Crs., 31.81% growth YoY, Total Income is Rs. 5,067 Crs., 31.69% growth YoY, Gross Profit is Rs. 2,576 Crs., 35.02% growth YoY, EBITDA is Rs. 1,373 Crs., 61.43% growth YoY, EBITDA Margin is 27.09% improved by 499 Basis points YoY, PBT Rs. 979 Crs., 70.04% growth YoY, PAT Rs. 759 Crs. 75.53% growth YoY. On QoQ basis Op. Revenue is up by 9.06%, Total Income is up by 9.2%, EBITDA is up by 16.64%, EBITDA Margin also improved by173 BPS, PBT is up by 29.33% and PAT is also up by 30.39%. Q1FY27 is an “extremely strong start” despite “volatile” macro (geopolitics, trade dynamics, supply-chain disruptions) and “uneven” demand in some end markets, attributing performance to portfolio diversification, execution discipline, and operational excellence. Specialty Chemicals cycle is turning, but not accelerating, Fluorochemicals strength is positioned as structural, not just seasonal, Fluoropolymers are the medium-term earnings lever.

#WatchOutFor#MacroViews#EquityResearch#TrendingSectors#FundamentalViews

1,034 likes·42 comments